Were Alice Yake’s XOS share sales made under a Rule 10b5-1 trading plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Alice Yake on September 29, 2025. Such plans pre-schedule trades according to predetermined instructions.

Xos director sells 7,500 shares in preset plan

Q: What does the Form 4/A filing report for XOS director Alice Yake?

It reports that Alice Yake sold 7,500 shares of Xos, Inc. common stock in three open-market transactions on July 15–17, 2026. The amendment corrects the transaction codes to show these were sales (Code "S") rather than dispositions to the issuer.

Q: How many XOS shares did Alice Yake sell on each transaction date?

Alice Yake sold 2,500 shares of Xos, Inc. common stock on July 15, 2026, 2,500 shares on July 16, 2026, and 2,500 shares on July 17, 2026, for a total of 7,500 shares sold.

Q: What were the sale prices for Alice Yake’s XOS stock sales?

The reported prices are weighted average sales prices. On July 15, 2026 the weighted average was $2.3042 with trades from $2.23–$2.40; on July 16 it was $2.1657 with trades from $2.12–$2.32; on July 17 it was $2.1481 with trades from $2.11–$2.18.

Q: What RSU holdings are disclosed for Alice Yake in this XOS filing?

A footnote states that the reported holdings include 60,584 unvested RSUs (restricted stock units). These RSUs represent rights to receive Xos, Inc. common shares in the future, subject to vesting conditions.

Xos, Inc. (XOS) director Alice Yake filed an amended Form 4 correcting prior transaction codes to show that three transactions in July 2026 were open-market sales (Code "S") of common stock, not dispositions to the issuer.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

4/A

Rhea-AI Filing Summary

Xos, Inc. (XOS) director Alice Yake filed an amended Form 4 correcting prior transaction codes to show that three transactions in July 2026 were open-market sales (Code "S") of common stock, not dispositions to the issuer. Yake sold a total of 7,500 shares on July 15–17, 2026 under a Rule 10b5-1 trading plan adopted on September 29, 2025, at weighted average prices around $2.15–$2.30 per share. Reported holdings include 60,584 unvested RSUs.

Insider Trade Summary 10b5-1

Net Seller: 7,500 shares

Net Sell 3 txns

Insider Yake Alice

Role Director

Sold 7,500 shs ($17K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F5, F3}	2,500	$2.1481	$5K
Sale	Common Stock ^{F1, F4, F3}	2,500	$2.1657	$5K
Sale	Common Stock ^{F1, F2, F3}	2,500	$2.3042	$6K

Holdings After Transaction: Common Stock — 152,561 shares (Direct)

Footnotes (5)

F1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.
F2. Represents weighted average sales price. The shares were sold at prices ranging from $2.23 to $2.40. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3. Includes 60,584 unvested RSUs.
F4. Represents weighted average sales price. The shares were sold at prices ranging from $2.12 to $2.32. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5. Represents weighted average sales price. The shares were sold at prices ranging from $2.11 to $2.18. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold July 15, 2026: 2,500 shares of Common Stock Weighted average price July 15, 2026: $2.3042 per share Shares sold July 16, 2026: 2,500 shares of Common Stock +5 more

8 metrics

Shares sold July 15, 2026 2,500 shares of Common Stock Open-market sale on July 15, 2026 (Code "S")

Weighted average price July 15, 2026 $2.3042 per share Sales ranged from $2.23 to $2.40

Shares sold July 16, 2026 2,500 shares of Common Stock Open-market sale on July 16, 2026 (Code "S")

Weighted average price July 16, 2026 $2.1657 per share Sales ranged from $2.12 to $2.32

Shares sold July 17, 2026 2,500 shares of Common Stock Open-market sale on July 17, 2026 (Code "S")

Weighted average price July 17, 2026 $2.1481 per share Sales ranged from $2.11 to $2.18

Total shares sold 7,500 shares Aggregate of three sales on July 15–17, 2026

Unvested RSUs included in holdings 60,584 RSUs Unvested RSUs included in reported holdings

Key Terms

Rule 10b5-1 trading plan, weighted average sales price, RSUs, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"were effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sales price financial

"Represents weighted average sales price. The shares were sold"

RSUs financial

"Includes 60,584 unvested RSUs."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Form 4 regulatory

"The transactions reported on this Form 4 were effected"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 4/A filing report for XOS director Alice Yake?

It reports that Alice Yake sold 7,500 shares of Xos, Inc. common stock in three open-market transactions on July 15–17, 2026. The amendment corrects the transaction codes to show these were sales (Code "S") rather than dispositions to the issuer.

How many XOS shares did Alice Yake sell on each transaction date?

Alice Yake sold 2,500 shares of Xos, Inc. common stock on July 15, 2026, 2,500 shares on July 16, 2026, and 2,500 shares on July 17, 2026, for a total of 7,500 shares sold.

What were the sale prices for Alice Yake’s XOS stock sales?

The reported prices are weighted average sales prices. On July 15, 2026 the weighted average was $2.3042 with trades from $2.23–$2.40; on July 16 it was $2.1657 with trades from $2.12–$2.32; on July 17 it was $2.1481 with trades from $2.11–$2.18.

What correction does this Form 4/A make to the prior XOS insider report?

The amendment explains that, due to an administrative error, the July 15–17, 2026 transactions were previously reported with Code "D". They are corrected to Code "S", indicating open-market sales, with no changes to any other reported information.

What RSU holdings are disclosed for Alice Yake in this XOS filing?

A footnote states that the reported holdings include 60,584 unvested RSUs (restricted stock units). These RSUs represent rights to receive Xos, Inc. common shares in the future, subject to vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/27/2026 - 07:30 AM EDT Accepted by SEC EDGAR 08/27/2026 - 07:30 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yake Alice

(Last)

(First)

(Middle)

C/O XOS, INC.

3550 TYBURN STREET, UNIT 100

(Street)

LOS ANGELES

CALIFORNIA

90065

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xos, Inc. [ XOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/17/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/15/2026		S		2,500⁽¹⁾	D	$2.3042⁽²⁾	157,561⁽³⁾	D
Common Stock	07/16/2026		S		2,500⁽¹⁾	D	$2.1657⁽⁴⁾	155,061⁽³⁾	D
Common Stock	07/17/2026		S		2,500⁽¹⁾	D	$2.1481⁽⁵⁾	152,561⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

2. Represents weighted average sales price. The shares were sold at prices ranging from $2.23 to $2.40. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

3. Includes 60,584 unvested RSUs.

4. Represents weighted average sales price. The shares were sold at prices ranging from $2.12 to $2.32. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

5. Represents weighted average sales price. The shares were sold at prices ranging from $2.11 to $2.18. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Remarks:

This Amendment is filed solely to correct the Transaction Codes for the transactions on July 15, 2026, July 16, 2026 and July 17, 2026. Due to an administrative error, the transactions were incorrectly reported using Code 'D'. The shares were actually sold on the open market pursuant to a Rule 10b5-1 trading plan as indicated in footnote 3, and should have been designated as Code 'S'. There are no changes to the other information reported in the original Form 4.

	/s/ David M. Zlotchew, Attorney-in-Fact for Alice Yake	08/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR